Berahyaluronidase alfa

Berahyaluronidase alfa (ALT-B4) is a hyaluronidase variant. Berahyaluronidase alfa is a fusion protein targeting Hyaluronidase PH-20, Sperm surface protein PH-20, HYAL3, Sperm adhesion molecule 1, PH20, SPAM1, Hyal-PH20, Hyaluronoglucosaminidase PH-20. Berahyaluronidase alfa can be used in the study of advanced and metastatic solid tumors[1].

2636716-20-4

ALT-B4

12352203

Glycosidase

Metabolic Enzyme/Protease

Cancer-programmed cell death

Cancer

[Berahyaluronidasealfa]

[1]Kopp-Kubel S. International Nonproprietary Names (INN) for pharmaceutical substances. Bull World Health Organ. 1995;73 (3) :275-9.|[2]Torras O R, et al. Abstract CT036: Bioavailability of MK-3475A (pembrolizumab with berahyaluronidase alfa; “subcutaneous pembrolizumab”) in participants with advanced or metastatic solid tumors[J]. Cancer Research, 2025, 85 (8_Supplement_2) : CT036-CT036

Room temperature

http://file.medchemexpress.com/batch_PDF/HY-P991212/

Inhibitory Antibodies

Launched